DES(5-METHYL-1,3,4-OXADIAZOLE-2-CARBOXAMIDE)-((E)-DIMETHYLAMINOMETHYLENEAMINO)RALTEGRAVIR
UNII UTE3M7YGV6
Substance Identification & Data
This profile provides standardized clinical and technical data for Des(5-methyl-1,3,4-oxadiazole-2-carboxamide)-((e)-dimethylaminomethyleneamino)raltegravir, uniquely identified by the FDA Unique Ingredient Identifier (UNII) UTE3M7YGV6.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1193687-85-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C19H24FN5O3 MEBOBLUKSXGASS-SSDVNMTOSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Des(5-methyl-1,3,4-oxadiazole-2-carboxamide)-((e)-dimethylaminomethyleneamino)raltegravir. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.